Her primary areas of investigation include Pathology, Virology, Immunology, Dermatology and Surgery. Her study in Virology is interdisciplinary in nature, drawing from both Cell culture, Subcellular localization and Molecular biology. Her biological study spans a wide range of topics, including Regulation of gene expression, Acquired immunodeficiency syndrome and Dementia.
Her Dermatology research is multidisciplinary, incorporating elements of Systemic disease, Lupus erythematosus, Connective tissue disease and Cutaneous lymphoma. She studied Lymphoma and Cancer that intersect with Cutaneous T-cell lymphoma and Peripheral T-cell lymphoma. Annamari Ranki has researched Virus in several fields, including Antibody and Immune system.
The scientist’s investigation covers issues in Immunology, Pathology, Virology, Dermatology and Internal medicine. In most of her Immunology studies, her work intersects topics such as Acquired immunodeficiency syndrome. Her Pathology research integrates issues from Cancer and Lymphocyte.
Her Virology research is multidisciplinary, incorporating perspectives in Epitope and Antibody. Within one scientific family, Annamari Ranki focuses on topics pertaining to Endocrinology under Internal medicine, and may sometimes address concerns connected to Receptor. Her study involves Mycosis fungoides, Cutaneous T-cell lymphoma and Cutaneous lymphoma, a branch of Lymphoma.
Annamari Ranki focuses on Immunology, Dermatology, Cutaneous T-cell lymphoma, Mycosis fungoides and Autoantibody. The study incorporates disciplines such as Microbiome, Human skin and Netherton syndrome in addition to Immunology. Her Dermatology research includes elements of Guideline and Hodgkin lymphoma.
Lymphoma covers Annamari Ranki research in Cutaneous T-cell lymphoma. Her research integrates issues of Cancer research and Transplantation in her study of Mycosis fungoides. Her Autoantibody research is multidisciplinary, relying on both Endocrinology, Autoimmunity, Disease and Autoimmune polyendocrine syndrome type 1.
Immunology, Mycosis fungoides, Dermatology, Guideline and Internal medicine are her primary areas of study. Her Immunology research incorporates elements of Transcriptome and Gene expression profiling. Her Mycosis fungoides study is concerned with the larger field of Lymphoma.
Annamari Ranki has included themes like Gastroenterology, Cancer, Real-time polymerase chain reaction and Immunofluorescence in her Lymphoma study. Her work carried out in the field of Dermatology brings together such families of science as Differential diagnosis, Lupus erythematosus and Systemic disease. Her Guideline research includes themes of Morphea, Dapsone, Thalidomide and Lenalidomide.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).
Elise Olsen;Eric Vonderheid;Nicola Pimpinelli;Rein Willemze.
GERMLINE MUTATIONS IN THE EXTRACELLULAR DOMAINS OF THE 55 KDA TNF RECEPTOR, TNFR1, DEFINE A FAMILY OF DOMINANTLY INHERITED AUTOINFLAMMATORY SYNDROMES
Michael F McDermott;Ivona Aksentijevich;Jérôme Galon;Elizabeth M McDermott.
Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases.
Rein Willemze;Patty M. Jansen;Lorenzo Cerroni;Emilio Berti.
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.
Elise A. Olsen;Sean Whittaker;Youn H. Kim;Madeleine Duvic.
Journal of Clinical Oncology (2011)
TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)
Youn H. Kim;Rein Willemze;Nicola Pimpinelli;Sean Whittaker.
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.
Franz Trautinger;Robert Knobler;Rein Willemze;Ketty Peris.
European Journal of Cancer (2006)
Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection.
Annamari Ranki;Annamari Ranki;Minerva Krohn;Minerva Krohn;Jean-Pierre Allain;Genoveffa Franchini.
The Lancet (1987)
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
Werner Kempf;Katrin Pfaltz;Maarten H. Vermeer;Antonio Cozzio.
MORPHOLOGICAL AND FUNCTIONAL CHARACTERIZATION OF ISOLATED EFFECTOR-CELLS RESPONSIBLE FOR HUMAN NATURAL KILLER ACTIVITY TO FETAL FIBROBLASTS AND TO CULTURED-CELL LINE TARGETS
E. Saksela;T. Timonen;Annamari Ranki;P. Hayry.
Immunological Reviews (1979)
Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets
Tuomo Timonen;Eero Saksela;Annamari Ranki;Pekka Häyry.
Cellular Immunology (1979)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: